AstraZeneca has completed the acquisition of Neogene Therapeutics
17 Jan 2023 //
PRESS RELEASE
AstraZeneca enters $320m deal to acquire Neogene
30 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
Neogen Completes 3M Food Safety Business Merger
01 Sep 2022 //
BIOSPACE
Neogene Nabs Approval of Clinical Trial Application for its First Phase 1 Trial
10 May 2022 //
BUSINESSWIRE
Neogene Therapeutics Appoints Han Lee, Ph.D., MBA, as Chief Financial Officer
14 Sep 2021 //
BUSINESSWIRE
Neogene taps Bristol Myers vet as U.S. COO—Chutes & Ladders
29 May 2021 //
FIERCE BIOTECH
Neogene Appoints Franz B. Humer as Executive Chairman of Board of Directors
06 Oct 2020 //
BUSINESSWIRE